Evidence map›Paper›PMID 39739100›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025

Spectrum and demographic profile of pediatric intraocular tumors from a single center in India: an analysis of 445 eyes.

Abhishek Das, Devu K Thulaseedharan, Parag K Shah, Prema Subramaniam, Narendran Venkatapathy

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abhishek DasDepartment of Pediatric Retina & Ocular Oncology, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Avinashi Road, Coimbatore, 641 014, Tamil Nadu, India. abdas.78@gmail.com.ORCID http://orcid.org/0000-0001-5658-631X
Devu K ThulaseedharanDepartment of Pediatric Retina & Ocular Oncology, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Avinashi Road, Coimbatore, 641 014, Tamil Nadu, India.
Parag K ShahDepartment of Pediatric Retina & Ocular Oncology, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Avinashi Road, Coimbatore, 641 014, Tamil Nadu, India.
Prema SubramaniamDepartment of Pediatric Retina & Ocular Oncology, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Avinashi Road, Coimbatore, 641 014, Tamil Nadu, India.
Narendran VenkatapathyDepartment of Pediatric Retina & Ocular Oncology, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Avinashi Road, Coimbatore, 641 014, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo describe the spectrum, demographic profile and distribution of intraocular oncology cases; both benign and malignant, in pediatric population in India.

methodsIt was a retrospective study done at a tertiary care hospital over a period of seven years (January 2015- December 2022) which included all the children aged 0-16 years, clinically diagnosed as intraocular tumors (benign or malignant) referred to our Ocular Oncology clinic. The data was retrieved from medical records department as well as electronic medical system (EMR) system. Age-wise distribution and demographic details were analyzed amongst these children.

resultsA total of 310 (n = 445) patients were included. Mean age at presentation was 28.80 ± 28.58 months (median, 22 months; range, 0-176). Males were 168 (54.2%) and females were 142 (45.9%). 43.9% of the patients were in the age group between 2 and 3 years. 69.1% of the patients travelled around 100-500 km for treatment. Mean duration of symptoms was 4.7 ± 8.9 months, mean time interval between symptom and visit to our hospital was 4.8 ± 8.9 months and mean total follow-up period was 34 ± 30.7 months (median, 25 months; range, 0-105). Leukocoria (65.5%) was the most common presenting symptom amongst all the patients. Most common intraocular tumor amongst all the age group was retinoblastoma (88.4%). This was followed by combined hamartoma of retina and retinal pigment epithelium (CHRRPE) (3%, n = 11), astrocytic hamartoma (2.6%, n = 15), retinocytoma (1.6%, n = 5), choroidal hemangioma (1%, n = 3), simple hamartoma of retinal pigment epithelium (RPE) (1%, n = 3), Medulloepithelioma (1%, n = 3) and others (2%).

conclusionThe most common malignant tumor was retinoblastoma and benign tumor was CHRRPE. Appropriate referral and early detection of these oncological diseases will play a crucial role in their prognosis and outcome.

Indexed as

Eye NeoplasmsAdolescentChildChild, PreschoolFemaleFollow-Up StudiesHumansIncidenceIndiaInfantInfant, NewbornMaleRetrospective StudiesCancerChildhood blindnessDeveloping countryIntraocular tumorsRetinoblastoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.